510(k) Report

510(k) · Cleared

Recalled · 2006

Stratus CS D-Dimer

K051597510(k) TraditionalCleared Aug 17, 200562-day reviewClass II21 CFR 864.7320Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Dade Behring, Inc. · DAP Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control

Cleared on Aug 17, 2005 as substantially equivalent to K022976 (Dade Behring, Inc., 2003) after a 62-day review. Its family tree reaches back 3 generations to 1986. 2 later devices descend from it. It has been recalled once.

Decided
Aug 17, 2005
Review
62 days
Class
Class II
Product code
DAP
Recalls
1
Predicates
1

Its longest line of descent runs back 3 generations to K862156 (1986). 2 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2007: 1 descendant cleared2008: 1 descendant clearedK862156 · Asserachrom D-DI Kit · American Bioproducts Co. · 1986K973819 · Vidas D-Dimer (DD) Assay · Biomerieux Vitek, Inc. · 1998K022976 · Stratus CS D-Dimer (DDMR) Method (Testpak & Dilpak), Models Cddmr & Cddmr-D · Dade Behring, Inc. · 2003 · recalled1990200020102020
  1. Root · 3 generations backK862156 Asserachrom D-DI KitAmerican Bioproducts Co. · 1986
  2. 2 generations backK973819 Vidas D-Dimer (DD) AssayBiomerieux Vitek, Inc. · 1998
  3. 1 generation backK022976 Stratus CS D-Dimer (DDMR) Method (Testpak & Dilpak), Models Cddmr &…Dade Behring, Inc. · 2003 · Recalled
  4. This deviceK051597 Stratus CS D-DimerDade Behring, Inc. · 2005
  5. Descendant · cites it directly · 1 of its ownK063356 Stratus CS Acute Care D-Dimer Testpak, Dilpak, CalpakDade Behring, Inc. · 2007 · Recalled
  6. Descendant · 2 generations on · 0 of its ownK081732 Innovance D-Dimer and Innovance D-Dimer ControlsSiemens Healthcare Diagnostics · 2008

Most influential descendants

Showing 2 of 2 · See all
  • K063356Stratus CS Acute Care D-Dimer Testpak, Dilpak, CalpakDade Behring, Inc. · 2007 · cites it directly1descendant
  • K081732Innovance D-Dimer and Innovance D-Dimer ControlsSiemens Healthcare Diagnostics · 2008 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K862156Asserachrom D-DI KitAmerican Bioproducts Co.1986—
−2K973819Vidas D-Dimer (DD) AssayBiomerieux Vitek, Inc.1998—
−1K022976Stratus CS D-Dimer (DDMR) Method (Testpak & Dilpak), Models Cddmr & Cddmr-DDade Behring, Inc.20031
0 (this device)K051597Stratus CS D-DimerDade Behring, Inc.2005—
+1K063356Stratus CS Acute Care D-Dimer Testpak, Dilpak, CalpakDade Behring, Inc.20071
+2K081732Innovance D-Dimer and Innovance D-Dimer ControlsSiemens Healthcare Diagnostics2008—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200710
200810
FIG. 1 — Lineage of K051597, 1986–2008Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DAP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DAP device

  1. #1 K253985 INNOVANCE® D-Dimer 2.0 (SMN 10873803)score 13.0 · 5 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K022976Stratus CS D-Dimer (DDMR) Method (Testpak & Dilpak), Models Cddmr & Cddmr-D
Summary page 1
…(HE) Product Code: DAP 3. Identification of the Legally Marketed Device: Stratus® CS D-Dimer (DDMR) Assay (K022976) 4. Device Description: The Stratus® CS DDMR procedure is a two-site sandwich assay based upon solid phase…
Dade Behring, Inc.20031

Also cleared against K022976: 2 other devices →

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K063356Stratus CS Acute Care D-Dimer Testpak, Dilpak, CalpakDade Behring, Inc.20071

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Apr 3, 2006Not classifiedZ-0877-06OtherFoil sealing of the TestPak may occlude the pipet tip resulting in insufficient aspiration of fluids. Erroneous test results may be generated without an associated error code. Test results may be falsely elevated or depressed, and the…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 19 years and passes through 3 companies; a new generation was cleared every 4.9 years on median.
  • 1 of the 3 ancestors has a recall of any class.
  • Of its descendants, K063356 (Dade Behring, Inc., 2007) has gone furthest, with 1 descendant of its own.
  • 2 other devices also cite its predicate K022976.

How does its category compare?

All DAP devices

DAP Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DAP

1in 2017

2007: 22008: 32009: 12010: 22011: 12012: 12014: 12015: 12016: 22017: 12026 (partial year): 1
2007high 3 (2008) · low 0 (2013)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DAP

127in 2008

2008: 127 days median
2007high 127 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DAP

2in 2025

2015: 12021: 12025: 2
2007high 2 (2025) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DAP

2in 2025

2007: 42008: 102009: 132010: 92011: 142012: 102013: 82014: 92015: 382016: 202017: 172018: 52019: 92020: 112021: 72022: 302023: 42024: 12025: 2
2007high 38 (2015) · low 1 (2024)2025

MAUDE reports naming product code DAP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—04
20083127010
20091—013
20102—09
20111—014
20121—010
20130—08
20141—09
20151—138
20162—020
20171—017
20180—05
20190—09
20200—011
20210—17
20220—030
20230—04
20240—01
20250—22
20261—0—

What is it indicated for?

The D-dimer (DDMR) method on the Stratus® CS STAT fluorometric analyzer is an in vitro diagnostic test for the quantitative measurement of cross-linked fibrin degradation products (D-dimer) in human citrated or heparinized plasma. The Stratus® CS DDMR method is intended for use as an aid in the diagnosis of venous thromboembolism (VTE) [deep vein thrombosis (DVT) or pulmonary embolism (PE)].

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K051597: Stratus CS D-Dimer.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K051597

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026